Skip to content
★ Sign in to follow
AM

Annemarie Moseley

Executive
Bellicum Pharmaceuticals, Inc
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€2.0M

Latest filing published 05 Dec 2016 for Bellicum Pharmaceuticals, INC, €60k.

Filing timeline

BuySale
Annemarie Moseley

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Annemarie Moseley: trading record in brief

Annemarie Moseley discloses dealings in Bellicum Pharmaceuticals, Inc to SEC (Form 4). We count 13 filings; the first trade dates from 1 July 2015 and the latest from 1 December 2016.

No open-market purchase appears, only 8 sales worth €2.0M. Besides market trades, the filings include 5 option exercises. Since January 2016: no purchases and 6 sales on the market.

Most recently, on 5 December 2016, the filings show an option exercise worth €60k in Bellicum Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Annemarie Moseley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations